Cargando…
Extracorporeal delivery of a therapeutic enzyme
To remove circulating harmful small biochemical(s)/substrates causing/deteriorating certain chronic disease, therapeutic enzyme(s) delivered via vein injection/infusion suffer(s) from immunoresponse after repeated administration at proper intervals for a long time and short half-lives since delivery...
Autores principales: | Zhang, Chun, Pu, Jun, Yang, Xiaolan, Feng, Tao, Liu, Fang, Wang, Deqiang, Hu, Xiaolei, Gao, Ang, Liu, Hongbo, Zhan, Chang-Guo, Liao, Fei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4967896/ https://www.ncbi.nlm.nih.gov/pubmed/27477538 http://dx.doi.org/10.1038/srep30888 |
Ejemplares similares
-
Data for high-throughput estimation of specific activities of enzyme/mutants in cell lysates through immunoturbidimetric assay of proteins
por: Feng, Yiran, et al.
Publicado: (2017) -
Comparison of activity indexes for recognizing enzyme mutants of higher activity with uricase as model
por: Feng, Juan, et al.
Publicado: (2013) -
Facile spectrophotometric assay of molar equivalents of
N-hydroxysuccinimide esters of monomethoxyl poly-(ethylene glycol)
derivatives
por: Gao, Ang, et al.
Publicado: (2012) -
Data for high-throughput screening of enzyme mutants by comparison of their activity ratios to an enzyme tag
por: Li, Yaping, et al.
Publicado: (2019) -
Delivery of therapeutic oligonucleotides in nanoscale
por: Wu, Lei, et al.
Publicado: (2021)